A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.

Kharfan-Dabaja, M A; Otrock, Z K; Bacigalupo, A; Mahfouz, R A; Geara, F; Bazarbachi, A

Kharfan-Dabaja, M A; Otrock, Z K; Bacigalupo, A; Mahfouz, R A; Geara, F; Bazarbachi, A.

Bone Marrow Transplant ; 47(9): 1254-5, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22246089

Subject(s)

Antilymphocyte Serum/therapeutic use; Cyclophosphamide/therapeutic use; Dyskeratosis Congenita/therapy; Hematopoietic Stem Cell Transplantation/methods; Transplantation Conditioning/methods; Vidarabine/analogs & derivatives; Whole-Body Irradiation/methods; Adult; Antilymphocyte Serum/administration & dosage; Antilymphocyte Serum/adverse effects; Combined Modality Therapy; Cyclophosphamide/adverse effects; Dyskeratosis Congenita/drug therapy; Dyskeratosis Congenita/surgery; Humans; Male; Vidarabine/adverse effects; Vidarabine/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Whole-Body Irradiation / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Dyskeratosis Congenita / Cyclophosphamide / Antilymphocyte Serum Limits: Adult / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2012 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google